ΤΙΓΚΑΣ ΣΤΕΛΙΟΣ (2014)


Papers

 Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
 Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial)
 Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
 Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
 Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes
 Incretin Therapy and Islet Pathology A Time for Caution
 Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glu
 Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus